BioSig Technologies, Inc. intends to offer shares of common stock through an underwritten public offering to purchase gold bullion and for general corporate purposes.
Clear Street and Needham & Company are joint book-running managers of the offering.
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC in 2024.
Proposed Public Offering
BioSig intends to offer shares of common stock for various purposes, including purchasing gold bullion and working capital.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is pursuant to a shelf registration statement on Form S-3 declared effective by the SEC in 2024.
- BioSig Technologies aims to raise capital through the public offering to support its investment policy.
- The involvement of Clear Street and Needham & Company as book-running managers adds credibility to the offering.
The proposed public offering by BioSig Technologies Inc. reflects the company's strategic approach to raise capital for its investment plans and operational needs.